News and Comments

HALOZYME: FINANCING PEGPH20 IS WORTH RAISING MONEY

  Wednesday, February 05, 2014

Halozyme Therapeutics (HALO) stock has been a loser yesterday while other biotech firms have rebounded after dipping during the few days’ of an angry market. The reason for the stock decline was the announcement of pricing of Halozyme’s previously announced underwritten public offering of 7,692,307 shares of its common stock at a public offering price of $13.00 per share.  More...


Recent Postings


Archive


Tags

Revlimid (lenolidamide) ARGOS (ARGS) Zerenex Ocular Therapeutix (OCUL) ARCA (ABIO) Aimmune Therapeutics (AIMT) Regeneron (REGN) Velcade (bortezomib) HALOZYME (HALO) Advaxis (ADXS) Biocryst (BCRX) Roche (RHHBY) galapagos (GLPG) Ionis (IONS) Intercept (ICPT) Roche (ROCHE) Multiple Myeloma Anacor (ANAC) Idenix (IDIX) Illumina (ILMN) Gilead (GILD) Inovio (INO) GUARDIAN HEALTH RenenxBio (RGNX) PTC Therapeutics (PTCT) Onyx (ONXX) Endometrial Cancer Alder Biopharmaceuticals (ALDR) Prolor Biotech (PBTH) Genentech Telaprevir ACADIA (ACAD) Sanofi-Aventis (SAN) GlaxoSmithKline (GSK) Sanofi (SNA) IDERA (IDRA) Vertex (VRTX) ABBVIE (ABBV) Pluristem (PSTI) Vitae Pharmaceuticals (VTAE) Herceptin Adaptimmune (ADAP) Sanofi (SNY) Prosensa (RNA) TOKAI (TKAOI) Rapamune Spike Therapeutics (ONCE) AstraZeneca (AZN) KITE (KITE) Dendreon (DNDN) Sarepta (SRPT) Biogen Idec (BIIB) Dynavax (DVAX) Human Genome Sciences (HGSI) Merck (MRK) ImmunoGen (IMGN) MODERNA Ariad (ARIA) Seattle Genetics (SGEN) AERIE PHARMACEUTICALS Agenus (AGEN) Intrexon (XON) REGULUS (RGLS) ZALTRAP™ Mirati Therapeutics (MRTX) Alnylam (ALNY) NANTKWEST (NK) SERES THERAPEUTICS (MCRB) Benlysta (belimumab) Exelixis (EXEL) ISIS (ISIS) Incyte (INCY) NOVOCURE (NVCR) KERYX (KERX) Human Longevity (HLI) Global Cell Therapeutics (GBT) CRISPR Therapeutics (CRSP) Sequenom (SQNM) Sangamo (SGMO) Agenus (AGEN AGOS (ARGS) OSI (OSIP) INNOVIVA (INVA) Theravance Bio Pharma (TBPH) C4 Therapeutics CompuGen (CGEN) SUNESIS PHARMACEUTICALS (SNSS) Tysabri Jazz Pharmaceuticals (JAZZ) Trastuzumab-DM1 Array Pharmaceuticals (ARRY) SYNTA (SNTA) Ziofpharm (ZIOP) VANDA (VNDA) NEKTAR (NKTR)) Bellicum (BLCM) Editas (EDIT) Intermune (ITMN) Ridaforolimus Bristol-Myers Squibb (BMY) Micromet (MITI) Xoma (XOMA) JUNO (JUNO) Theravance (THRX) Valeant Pharmaceuticals International (VRX) CEMPRA (CEMP) ADVENTRIX (ANX) Galena (GALE) Amgen (AMGN) Anadys (ANDS) Cytokinetics (CYTK) Auspex (ASPX) Elan (ELN) BIOMARIN (BMRN) Abbott Laboratories (ABT)